Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Knytl, Pavel, Veronika Vorá?ková, Aneta Dorazilová, Mabel Rodriguez, Aneta Cvr?ková, Edita Kofro?ová, Martin Kucha? et al. "Neuroactive steroids and cognitive functions in first-episode psychosis patients and their healthy siblings." Frontiers in psychiatry 10 (2019): 390. |
|
Khandaker, Golam M., Stanley Zammit, Glyn Lewis, and Peter B. Jones. "A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence." Schizophrenia research 152, no. 1 (2014): 139-145. |
|
Dorado Ramírez, Carlos Alberto, and Daniela Castaño Correa. "Effectiveness of Computerized Programs in Cognitive Rehabilitation of Patients with Schizophrenia." Pensamiento Psicológico 16, no. 2 (2018): 73-86. |
|
Greenhalgh, Anne Marie, Leticia Gonzalez-Blanco, Clemente Garcia-Rizo, Emilio Fernandez-Egea, Brian Miller, Miguel Bernardo Arroyo, and Brian Kirkpatrick. "Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis." Schizophrenia research 179 (2017): 57-63. |
|
Borroto-Escuela, Dasiel O., Jens Carlsson, Patricia Ambrogini, Manuel Narváez, Karolina Wydra, Alexander O. Tarakanov, Xiang Li et al. "Understanding the role of GPCR heteroreceptor complexes in modulating the brain networks in health and disease." Frontiers in cellular neuroscience 11 (2017): 37. |
|
Singh, Bisu, and Tapas Kumar Chaudhuri. "Role of C-reactive protein in schizophrenia: an overview." Psychiatry research 216, no. 2 (2014): 277-285. |
|
Carolus, Almut Maria. "Functional Cortical and Cognitive Abnormalities in First-episode Schizophrenia Patients: Impact of Training." PhD diss., 2015. |
|
Sholler, Dennis J., Marilyn A. Huestis, Benjamin Amendolara, Ryan Vandrey, and Ziva D. Cooper. "Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids." Pharmacology Biochemistry and Behavior (2020): 173059. |
|
Shorter, Kimberly R., and Brooke H. Miller. "Epigenetic mechanisms in schizophrenia." Progress in biophysics and molecular biology 118, no. 1-2 (2015): 1-7. |
|
Joseph, Jamie, Colin Depp, Averria Sirkin Martin, Rebecca E. Daly, Danielle K. Glorioso, Barton W. Palmer, and Dilip V. Jeste. "Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups." Schizophrenia research 168, no. 1-2 (2015): 456-460. |
|
Tomaselli, Giovanni, and Monique Vallée. "Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway." Frontiers in neuroendocrinology 55 (2019): 100789. |
|
Wallace, Tanya L., and Daniel Bertrand. "Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia." Expert opinion on therapeutic targets 17, no. 2 (2013): 139-155. |
|
Metcalf, Stephen A., Peter B. Jones, Tanja Nordstrom, Markku Timonen, Pirjo Mäki, Jouko Miettunen, Erika Jääskeläinen et al. "Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study." Brain, behavior, and immunity 59 (2017): 253-259. |
|
Nahum, Mor, Michael Merzenich, Christine Hooker, Joseph Ventura, Michael F. Green, Melissa Fisher, Sophia Vinogradov, and Annika Rose. "Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol." (2015). |
|
Chan, Man K., Michael G. Gottschalk, Frieder Haenisch, Jakub Tomasik, Tillmann Ruland, Hassan Rahmoune, Paul C. Guest, and Sabine Bahn. "Applications of blood-based protein biomarker strategies in the study of psychiatric disorders." Progress in neurobiology 122 (2014): 45-72. |
|
Roisum, Rachel, Danielle Jenkins, Melissa Fisher, Ariel Currie, Sisi Ma, Christopher Lindgren, Piper Meyer-Kalos, and Sophia Vinogradov. "Targeting Cognition and Motivation in Coordinated Specialty Care for Early Psychosis: A Grant Report." Journal of psychiatry and brain science 5 (2020). |
|
Salama, Hamed A., Azza A. Mahmoud, Amany O. Kamel, Mayssa Abdel Hady, and Gehanne AS Awad. "Brain delivery of olanzapine by intranasal administration of transfersomal vesicles." Journal of liposome research 22, no. 4 (2012): 336-345. |
|
Melbourne, Jennifer K., Benjamin Feiner, Cherise Rosen, and Rajiv P. Sharma. "Targeting the immune system with pharmacotherapy in schizophrenia." Current treatment options in psychiatry 4, no. 2 (2017): 139-151. |
|
De Picker, Livia J., Manuel Morrens, Steven A. Chance, and Delphine Boche. "Microglia and brain plasticity in acute psychosis and schizophrenia illness course: a meta-review." Frontiers in psychiatry 8 (2017): 238. |
|
Misiak, B?a?ej, Filip Stramecki, ?ukasz Gaw?da, Katarzyna Prochwicz, Maria M. S?siadek, Ahmed A. Moustafa, and Dorota Frydecka. "Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: a systematic review." Molecular neurobiology 55, no. 6 (2018): 5075-5100. |
|